JPH11506363A - アイケア製品中の眼の病原体の増殖を防止するためのポリマー、物品および方法 - Google Patents
アイケア製品中の眼の病原体の増殖を防止するためのポリマー、物品および方法Info
- Publication number
- JPH11506363A JPH11506363A JP8534965A JP53496596A JPH11506363A JP H11506363 A JPH11506363 A JP H11506363A JP 8534965 A JP8534965 A JP 8534965A JP 53496596 A JP53496596 A JP 53496596A JP H11506363 A JPH11506363 A JP H11506363A
- Authority
- JP
- Japan
- Prior art keywords
- polymer
- compound
- eye care
- formula
- care product
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 230000012010 growth Effects 0.000 title claims abstract description 35
- 244000000073 ocular pathogen Species 0.000 title claims abstract description 15
- 229920000642 polymer Polymers 0.000 title claims description 83
- 238000000034 method Methods 0.000 title claims description 32
- 150000001768 cations Chemical class 0.000 claims abstract description 41
- 239000000463 material Substances 0.000 claims abstract description 11
- 150000001875 compounds Chemical class 0.000 claims description 42
- 125000000217 alkyl group Chemical group 0.000 claims description 21
- 239000000126 substance Substances 0.000 claims description 20
- 229910052739 hydrogen Inorganic materials 0.000 claims description 18
- -1 alkali metal cation Chemical class 0.000 claims description 15
- 239000007787 solid Substances 0.000 claims description 14
- 229910052783 alkali metal Inorganic materials 0.000 claims description 13
- 239000000178 monomer Substances 0.000 claims description 13
- 241000894006 Bacteria Species 0.000 claims description 8
- 125000002768 hydroxyalkyl group Chemical group 0.000 claims description 8
- 244000052769 pathogen Species 0.000 claims description 8
- 241000233866 Fungi Species 0.000 claims description 7
- 238000004519 manufacturing process Methods 0.000 claims description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 5
- 239000007788 liquid Substances 0.000 claims description 4
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 3
- 238000006243 chemical reaction Methods 0.000 claims description 3
- 239000001257 hydrogen Substances 0.000 claims description 3
- 230000003472 neutralizing effect Effects 0.000 claims description 2
- 230000000379 polymerizing effect Effects 0.000 claims description 2
- 125000002947 alkylene group Chemical group 0.000 claims 3
- 150000002118 epoxides Chemical class 0.000 claims 3
- 125000001301 ethoxy group Chemical group [H]C([H])([H])C([H])([H])O* 0.000 claims 2
- 230000002401 inhibitory effect Effects 0.000 claims 1
- 239000002738 chelating agent Substances 0.000 abstract description 8
- 239000000047 product Substances 0.000 description 15
- 239000000243 solution Substances 0.000 description 12
- 241000224422 Acanthamoeba Species 0.000 description 9
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 6
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 6
- 239000013522 chelant Substances 0.000 description 6
- OSVXSBDYLRYLIG-UHFFFAOYSA-N dioxidochlorine(.) Chemical compound O=Cl=O OSVXSBDYLRYLIG-UHFFFAOYSA-N 0.000 description 6
- 241000224489 Amoeba Species 0.000 description 5
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 5
- 239000000017 hydrogel Substances 0.000 description 5
- 239000000203 mixture Substances 0.000 description 5
- 229920002818 (Hydroxyethyl)methacrylate Polymers 0.000 description 4
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 4
- WOBHKFSMXKNTIM-UHFFFAOYSA-N Hydroxyethyl methacrylate Chemical compound CC(=C)C(=O)OCCO WOBHKFSMXKNTIM-UHFFFAOYSA-N 0.000 description 4
- 208000031513 cyst Diseases 0.000 description 4
- 150000002924 oxiranes Chemical class 0.000 description 4
- 238000006116 polymerization reaction Methods 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 239000004155 Chlorine dioxide Substances 0.000 description 3
- 206010011732 Cyst Diseases 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 239000000460 chlorine Substances 0.000 description 3
- 235000019398 chlorine dioxide Nutrition 0.000 description 3
- 230000002538 fungal effect Effects 0.000 description 3
- 208000015181 infectious disease Diseases 0.000 description 3
- 206010023332 keratitis Diseases 0.000 description 3
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- 241000922028 Acanthamoeba astronyxis Species 0.000 description 2
- 241000224423 Acanthamoeba castellanii Species 0.000 description 2
- 241000167877 Acanthamoeba culbertsoni Species 0.000 description 2
- 241001147680 Acanthamoeba lenticulata Species 0.000 description 2
- 241001455958 Acanthamoeba rhysodes Species 0.000 description 2
- 239000004342 Benzoyl peroxide Substances 0.000 description 2
- OMPJBNCRMGITSC-UHFFFAOYSA-N Benzoylperoxide Chemical compound C=1C=CC=CC=1C(=O)OOC(=O)C1=CC=CC=C1 OMPJBNCRMGITSC-UHFFFAOYSA-N 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 235000019400 benzoyl peroxide Nutrition 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 235000021321 essential mineral Nutrition 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- 239000011159 matrix material Substances 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- 229910017464 nitrogen compound Inorganic materials 0.000 description 2
- 150000002830 nitrogen compounds Chemical class 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 230000035764 nutrition Effects 0.000 description 2
- 239000002997 ophthalmic solution Substances 0.000 description 2
- 239000007800 oxidant agent Substances 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 239000004417 polycarbonate Substances 0.000 description 2
- 229920000515 polycarbonate Polymers 0.000 description 2
- 239000004800 polyvinyl chloride Substances 0.000 description 2
- 229920000915 polyvinyl chloride Polymers 0.000 description 2
- QQONPFPTGQHPMA-UHFFFAOYSA-N propylene Natural products CC=C QQONPFPTGQHPMA-UHFFFAOYSA-N 0.000 description 2
- 125000004805 propylene group Chemical group [H]C([H])([H])C([H])([*:1])C([H])([H])[*:2] 0.000 description 2
- 239000011541 reaction mixture Substances 0.000 description 2
- OEPOKWHJYJXUGD-UHFFFAOYSA-N 2-(3-phenylmethoxyphenyl)-1,3-thiazole-4-carbaldehyde Chemical compound O=CC1=CSC(C=2C=C(OCC=3C=CC=CC=3)C=CC=2)=N1 OEPOKWHJYJXUGD-UHFFFAOYSA-N 0.000 description 1
- FPWSFGKGWVUHTF-UHFFFAOYSA-N 2-hydroxyethyl 2-methylbut-2-enoate Chemical compound CC=C(C)C(=O)OCCO FPWSFGKGWVUHTF-UHFFFAOYSA-N 0.000 description 1
- 241000207965 Acanthaceae Species 0.000 description 1
- 241000921991 Acanthamoeba hatchetti Species 0.000 description 1
- 206010069408 Acanthamoeba keratitis Diseases 0.000 description 1
- 241000224430 Acanthamoeba polyphaga Species 0.000 description 1
- 241000224424 Acanthamoeba sp. Species 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 description 1
- 241000222122 Candida albicans Species 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- RWSOTUBLDIXVET-UHFFFAOYSA-N Dihydrogen sulfide Chemical compound S RWSOTUBLDIXVET-UHFFFAOYSA-N 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- CERQOIWHTDAKMF-UHFFFAOYSA-N Methacrylic acid Chemical compound CC(=C)C(O)=O CERQOIWHTDAKMF-UHFFFAOYSA-N 0.000 description 1
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 description 1
- 241001427555 Polyphaga <Blattaria> Species 0.000 description 1
- 239000004721 Polyphenylene oxide Substances 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- 241000607715 Serratia marcescens Species 0.000 description 1
- 206010064996 Ulcerative keratitis Diseases 0.000 description 1
- XTXRWKRVRITETP-UHFFFAOYSA-N Vinyl acetate Chemical compound CC(=O)OC=C XTXRWKRVRITETP-UHFFFAOYSA-N 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 150000001252 acrylic acid derivatives Chemical class 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 239000004599 antimicrobial Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 239000012298 atmosphere Substances 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 230000037358 bacterial metabolism Effects 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 159000000007 calcium salts Chemical class 0.000 description 1
- 239000011951 cationic catalyst Substances 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 230000036978 cell physiology Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 229910001919 chlorite Inorganic materials 0.000 description 1
- 229910052619 chlorite group Inorganic materials 0.000 description 1
- QBWCMBCROVPCKQ-UHFFFAOYSA-N chlorous acid Chemical compound OCl=O QBWCMBCROVPCKQ-UHFFFAOYSA-N 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 239000000882 contact lens solution Substances 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 201000007717 corneal ulcer Diseases 0.000 description 1
- 238000009795 derivation Methods 0.000 description 1
- 239000000645 desinfectant Substances 0.000 description 1
- 230000003292 diminished effect Effects 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 238000005886 esterification reaction Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 230000002070 germicidal effect Effects 0.000 description 1
- 230000036571 hydration Effects 0.000 description 1
- 238000006703 hydration reaction Methods 0.000 description 1
- 125000001145 hydrido group Chemical group *[H] 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 125000001841 imino group Chemical group [H]N=* 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 239000011261 inert gas Substances 0.000 description 1
- 230000002458 infectious effect Effects 0.000 description 1
- 239000003999 initiator Substances 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 230000033001 locomotion Effects 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 150000002734 metacrylic acid derivatives Chemical class 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 229940054534 ophthalmic solution Drugs 0.000 description 1
- 150000007530 organic bases Chemical class 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 238000009832 plasma treatment Methods 0.000 description 1
- 229920000570 polyether Polymers 0.000 description 1
- 239000012985 polymerization agent Substances 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 239000011118 polyvinyl acetate Substances 0.000 description 1
- 229920002689 polyvinyl acetate Polymers 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 125000001453 quaternary ammonium group Chemical group 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 230000001360 synchronised effect Effects 0.000 description 1
- 210000003812 trophozoite Anatomy 0.000 description 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L12/00—Methods or apparatus for disinfecting or sterilising contact lenses; Accessories therefor
- A61L12/08—Methods or apparatus for disinfecting or sterilising contact lenses; Accessories therefor using chemical substances
- A61L12/14—Organic compounds not covered by groups A61L12/10 or A61L12/12
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L12/00—Methods or apparatus for disinfecting or sterilising contact lenses; Accessories therefor
- A61L12/08—Methods or apparatus for disinfecting or sterilising contact lenses; Accessories therefor using chemical substances
- A61L12/086—Container, accessories or devices therefor
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C229/06—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton
- C07C229/10—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton the nitrogen atom of the amino group being further bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings
- C07C229/16—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton the nitrogen atom of the amino group being further bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings to carbon atoms of hydrocarbon radicals substituted by amino or carboxyl groups, e.g. ethylenediamine-tetra-acetic acid, iminodiacetic acids
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C08F20/00—Homopolymers and copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical or a salt, anhydride, ester, amide, imide or nitrile thereof
- C08F20/02—Monocarboxylic acids having less than ten carbon atoms, Derivatives thereof
- C08F20/10—Esters
- C08F20/34—Esters containing nitrogen, e.g. N,N-dimethylaminoethyl (meth)acrylate
- C08F20/36—Esters containing nitrogen, e.g. N,N-dimethylaminoethyl (meth)acrylate containing oxygen in addition to the carboxy oxygen, e.g. 2-N-morpholinoethyl (meth)acrylate or 2-isocyanatoethyl (meth)acrylate
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Polymers & Plastics (AREA)
- Medicinal Chemistry (AREA)
- Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
- Apparatus For Disinfection Or Sterilisation (AREA)
- Eyeglasses (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Treatments Of Macromolecular Shaped Articles (AREA)
- Packages (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Abstract
Description
Claims (1)
- 【特許請求の範囲】 1.眼の病原体の増殖を防止できる多価カチオンキレートポリマー。 2.眼の病原体が、原生動物、バクテリアおよび菌からなる群から選択される 請求項1記載のポリマー。 3.原生動物の増殖を防止できる請求項1記載のポリマー。 4.多価カチオンをキレートできる少なくとも1種の部分を効果的に増殖を防 止できる量で含んでなる請求項1記載のポリマー。 5.多価カチオンをキレートできる部分を有する少なくとも1種のモノマー単 位を約1〜100重量%の量で含んでなる請求項1に記載のポリマー。 6.該部分が、−N(CH2CO2A)2基または−N(CH2CO2A)3Cl基 であり、Aが水素またはアルカリ金属カチオンである請求項1に記載のポリマー 。 7.式(I): [式中、 R1、R2、R3は、独立してHまたはC1 〜6のアルキル基であり、 R4は、一重結合またはC1 〜6のアルキレンオキシ基であり、 R5、R6、R7、R8、R9は、独立してHまたはC1 〜6のアルキル基であり、 nは、0〜18の整数であり、 Aは、Hまたはアルカリ金属カチオンであり、 xは、2または3であり、および yは、xが2である場合0であり、xが3である場合1である。] を有するモノマー単位を複数で含んでなる請求項1記載のポリマー。 8.さらに、少なくとも1種の付加的なエチレン性不飽和コモノマー単位を複 数で含んでなる請求項7記載のポリマー。 9.該コモノマー単位が、式(II): [式中、 R1、R2、R3は、独立して、HまたはC1 〜6アルキル基であり、 R4'は、HまたはC1 〜6ヒドロキシアルキル基である。] を有する請求項8に記載のポリマー。 10.式(III): [式中、 R1、R2、R3は、独立してHまたはC1〜6のアルキル基であり、 R4は、一重結合またはC1 〜6のアルキレンオキシ基であり、 R5、R6、R7、R8、R9は、独立してHまたはC1 〜6のアルキル基であり、 nは、0〜18の整数であり、 Aは、Hまたはアルカリ金属カチオンであり、 xは、2または3であり、および yは、xが2である場合0であり、xが3である場合1である。] を有する化合物。 11.R1およびR2が、Hである請求項10記載の化合物。 12.R3がCH3である請求項10記載の化合物。 13.R5、R6、R7、R8およびR9がHである請求項10記載の化合物。 14.R4が、一重結合またはエトキシ基である請求項10記載の化合物。 15.Aが、HまたはNaである請求項10記載の化合物。 16.nが12である請求項10記載の化合物。 17.R1、R2、R5、R6、R7、R8およびR9がHであり、R3がCH3であ り、R4が一重結合またはエトキシ基であり、AがHまたはNaであり、nが1 2である請求項10記載の化合物。 18.エポキシドと反応できる物質と、式(IV): [式中、 R5、R6、R7、R8、R9は、独立してHまたはC1 〜6のアルキル基であり、 nは、0〜18の整数であり、 Aは、Hまたはアルカリ金属カチオンであり、 xは、2または3であり、および yは、xが2である場合0であり、xが3である場合1である。] で示される化合物を反応させる工程を含んでなる多価カチオンをキレートできる 物質の製造方法。 19.エポキシドと反応できる物質が、表面ラジカルを有するプラズマ処理さ れた固体ポリマーである請求項18記載の方法。 20.反応が、 (i)式(IV)を有する化合物を含んでなる溶液または低圧蒸気にポリマーを曝 露して、誘導化された固体ポリマーを形成する工程、 (ii)固体ポリマーを低圧で水蒸気または液状水に曝露することによって、誘導 化された固体ポリマー上に残っている表面ラジカルを中和する工程 を含んでなる請求項19記載の方法。 21.エポキシドと反応できる物質が、式(V): [式中、 R1、R2、R3は、独立して、HまたはC1 〜6アルキル基であり、および R4'は、HまたはC1 〜6ヒドロキシアルキル基である。] で示される化合物である請求項18記載の方法。 22.式(IV)の化合物と式(V)の化合物を反応して、式(III): [式中、 R1、R2、R3は独立してHまたはC1 〜6のアルキル基であり、 R4は、一重結合またはC1 〜6のアルキレンオキシ基であり、 R5、R6、R7、R8、R9は、独立してHまたはC1 〜6のアルキル基であり、 nは、0〜18の整数であり、 Aは、Hまたはアルカリ金属カチオンであり、 xは、2または3であり、および yは、xが2である場合0であり、xが3である場合1である。] で示される化合物を形成する工程を含んでなる請求項21記載の方法。 23.請求項10記載の式(III)の化合物を重合する工程を含んでなる多価 カチオンをキレートできる物質を製造する方法。 24.式(III)の化合物を、少なくとも1種の付加的なエチレン性不飽和化 合物と共重合する請求項23記載の方法。 25.請求項18記載の方法によって製造された物質。 26.請求項19記載の方法によって製造された物質。 27.請求項20記載の方法によって製造された物質。 28.請求項21記載の方法によって製造された物質。 29.請求項1記載のポリマーを含んでなるアイケア製品。 30.請求項7記載のポリマーを含んでなるアイケア製品。 31.該ポリマーで被覆された表面を有する請求項30記載のアイケア製品。 32.コンタクトレンズケースまたは眼用のまたはコンタタクトレンズのケア 溶液のための容器である請求項31記載のアイケア製品。 33.請求項9記載のポリマーを含んでなるアイケア製品。 34.コンタクトレンズである請求項33記載のアイケア製品。 35.請求項25記載の物質を含んでなるアイケア製品。 36.請求項26記載の物質を含んでなるアイケア製品。 37.コンタクトレンズケースまたは眼のまたはコンタクトレンズのケア溶液 のための容器である請求項36記載のアイケア製品。 38.請求項25記載の物質を含んでなるアイケア製品。 39.請求項26記載の物質を含んでなるアイケア製品。 40.コンタクトレンズである請求項38記載のアイケア製品。 41.コンタクトレンズである請求項39記載のアイケア製品。 42.請求項29記載のアイケア製品と溶液を接触させる工程を含んでなる、 眼用のまたはコンタクトレンズのアイケア溶液中の眼の病原体の増殖を防止する 方法。 43.請求項35記載のアイケア製品と溶液を接触させる工程を含んでなる、 眼用のまたはコンタクトレンズのアイケア溶液中の眼の病原体の増殖を防止する 方法。 44.請求項36記載のコンタクトレンズケース中に含まれるアイケア溶液中 にレンズを浸漬する工程を含んでなる、コンタクトレンズの表面で眼の病原体の 増殖を防止する方法。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/440,579 US5739178A (en) | 1995-05-15 | 1995-05-15 | Polymer, article and method for inhibiting the growth of ocular pathogens in eye care products |
US08/440,579 | 1995-05-15 | ||
PCT/US1996/006839 WO1996036371A1 (en) | 1995-05-15 | 1996-05-13 | Polymer, article and method for inhibiting the growth of ocular pathogens in eye care products |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2003426591A Division JP4091536B2 (ja) | 1995-05-15 | 2003-12-24 | 多価カチオンをキレートできる化合物の製造方法およびアイケア製品 |
Publications (2)
Publication Number | Publication Date |
---|---|
JPH11506363A true JPH11506363A (ja) | 1999-06-08 |
JP3641667B2 JP3641667B2 (ja) | 2005-04-27 |
Family
ID=23749322
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP53496596A Expired - Fee Related JP3641667B2 (ja) | 1995-05-15 | 1996-05-13 | アイケア製品中の眼の病原体の増殖を防止するためのポリマー、物品および方法 |
JP2003426591A Expired - Lifetime JP4091536B2 (ja) | 1995-05-15 | 2003-12-24 | 多価カチオンをキレートできる化合物の製造方法およびアイケア製品 |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2003426591A Expired - Lifetime JP4091536B2 (ja) | 1995-05-15 | 2003-12-24 | 多価カチオンをキレートできる化合物の製造方法およびアイケア製品 |
Country Status (7)
Country | Link |
---|---|
US (2) | US5739178A (ja) |
EP (1) | EP0828522B1 (ja) |
JP (2) | JP3641667B2 (ja) |
AU (1) | AU702481B2 (ja) |
CA (1) | CA2221132C (ja) |
DE (1) | DE69613694T2 (ja) |
WO (1) | WO1996036371A1 (ja) |
Families Citing this family (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5739178A (en) * | 1995-05-15 | 1998-04-14 | Allergan | Polymer, article and method for inhibiting the growth of ocular pathogens in eye care products |
US6143849A (en) * | 1996-11-27 | 2000-11-07 | The United States Of America As Represented By The Secretary Of The Navy | Synthesis of acrylate and alkyl acrylate monomers and polymers of chelators |
FR2777360B1 (fr) * | 1998-04-14 | 2000-06-30 | Sofab | Dispositif de conditionnement et de traitement bactericide pour lentilles de contact |
US6596401B1 (en) | 1998-11-10 | 2003-07-22 | C. R. Bard Inc. | Silane copolymer compositions containing active agents |
US7678836B2 (en) | 1999-11-04 | 2010-03-16 | Fxs Ventures, Llc | Method for rendering a contact lens wettable |
US6716895B1 (en) | 1999-12-15 | 2004-04-06 | C.R. Bard, Inc. | Polymer compositions containing colloids of silver salts |
US7179849B2 (en) * | 1999-12-15 | 2007-02-20 | C. R. Bard, Inc. | Antimicrobial compositions containing colloids of oligodynamic metals |
US6579539B2 (en) | 1999-12-22 | 2003-06-17 | C. R. Bard, Inc. | Dual mode antimicrobial compositions |
US8557868B2 (en) * | 2000-11-04 | 2013-10-15 | Fxs Ventures, Llc | Ophthalmic and contact lens solutions using low molecular weight amines |
US9492582B2 (en) * | 2000-11-08 | 2016-11-15 | Fxs Ventures, Llc | Ophthalmic and contact lens solutions containing simple saccharides as preservative enhancers |
US9308264B2 (en) | 2000-11-08 | 2016-04-12 | Fxs Ventures, Llc | Ophthalmic contact lens solutions containing forms of vitamin B |
US20070098813A1 (en) * | 2000-11-08 | 2007-05-03 | Fxs Ventures, Llc | Ophthalmic and contact lens solutions with a peroxide source and a preservative |
CA2428985C (en) * | 2000-11-08 | 2011-05-24 | Bio-Concept Laboratories | Improved ophthalmic and contact lens solutions containing simple saccharides as preservative enhancers |
US20060148665A1 (en) * | 2000-11-08 | 2006-07-06 | Bioconcept Laboratories | Ophthalmic and contact lens solutions containing forms of vitamin b |
ATE405265T1 (de) * | 2000-11-08 | 2008-09-15 | Fxs Ventures Llc | Verbesserte ophthalmologische und kontaktlinsenlösungen mit vitamin-b-formen |
US6624203B1 (en) | 2001-11-08 | 2003-09-23 | Francis X. Smith | Nucleic acid bases used in ophthalmic solutions |
US6617291B1 (en) | 2001-11-08 | 2003-09-09 | Francis X. Smith | Ophthalmic and contact lens solutions |
AU2002357050A1 (en) * | 2001-12-03 | 2003-06-17 | C.R. Bard, Inc. | Microbe-resistant medical device, microbe-resistant polymeric coating and methods for producing same |
WO2004091438A2 (en) * | 2003-04-15 | 2004-10-28 | Fxs Ventures, Llc | Improved ophthalmic and contact lens solutions containing peptides as representative enhancers |
US7384545B2 (en) * | 2004-04-13 | 2008-06-10 | Eastman Kodak Company | Container for inhibiting microbial growth in liquid nutrients |
US7361275B2 (en) * | 2004-04-13 | 2008-04-22 | Eastman Kodak Company | Use of derivatized nanoparticles to minimize growth of micro-organisms in hot filled drinks |
US7311933B2 (en) * | 2004-04-13 | 2007-12-25 | Eastman Kodak Company | Packaging material for inhibiting microbial growth |
US7258786B2 (en) * | 2004-04-13 | 2007-08-21 | Eastman Kodak Company | Container for inhibiting microbial growth in liquid nutrients |
US7357863B2 (en) * | 2004-04-13 | 2008-04-15 | Eastman Kodak Company | Container for inhibiting microbial growth in liquid nutrients |
US20050226911A1 (en) * | 2004-04-13 | 2005-10-13 | Bringley Joseph F | Article for inhibiting microbial growth in physiological fluids |
US7357979B2 (en) * | 2004-04-13 | 2008-04-15 | Eastman Kodak Company | Composition of matter comprising polymer and derivatized nanoparticles |
US7381334B2 (en) * | 2004-04-13 | 2008-06-03 | Eastman Kodak Company | Method for inhibiting microbial growth in liquid nutrients |
US7323109B2 (en) * | 2004-06-15 | 2008-01-29 | Eastman Kodak Company | Composition comprising metal-ion sequestrant |
US20050276862A1 (en) * | 2004-06-15 | 2005-12-15 | Bringley Joseph F | Iron sequestering antimicrobial composition |
US20230242323A1 (en) * | 2020-06-16 | 2023-08-03 | Sio2 Medical Products, Inc. | Packages comprising anti-microbial coatings for preventing contamination, e.g. after first use of the product |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS4835372B1 (ja) * | 1969-05-28 | 1973-10-27 | ||
JPS5010624B1 (ja) * | 1971-07-01 | 1975-04-23 | ||
US4499077A (en) * | 1981-02-03 | 1985-02-12 | Stockel Richard F | Anti-microbial compositions and associated methods for preparing the same and for the disinfecting of various objects |
US4551461A (en) * | 1982-06-01 | 1985-11-05 | Sherman Laboratories, Inc. | Soft contact lens ambient temperature disinfectant and rinsing solution and method |
US4654208A (en) * | 1983-03-01 | 1987-03-31 | Stockel Richard F | Anti-microbial compositions comprising an aqueous solution of a germicidal polymeric nitrogen compound and a potentiating oxidizing agent |
US5124359A (en) * | 1987-12-22 | 1992-06-23 | Cetylite Industries, Inc. | Sterilant composition |
US5486357A (en) * | 1990-11-08 | 1996-01-23 | Cordis Corporation | Radiofrequency plasma biocompatibility treatment of inside surfaces |
JPH05287685A (ja) * | 1992-04-02 | 1993-11-02 | Nippon Shokubai Co Ltd | セルロース系繊維の染色方法 |
IL110099A0 (en) * | 1993-07-22 | 1994-10-07 | Johnson & Johnson Vision Prod | Anti-bacterial, insoluble, metal-chelating polymers |
US5382599A (en) * | 1993-10-13 | 1995-01-17 | Allergan, Inc. | Method of inhibiting protozoan growth in eye care products using a polyvalent cation chelating agent |
US5739178A (en) * | 1995-05-15 | 1998-04-14 | Allergan | Polymer, article and method for inhibiting the growth of ocular pathogens in eye care products |
-
1995
- 1995-05-15 US US08/440,579 patent/US5739178A/en not_active Expired - Fee Related
-
1996
- 1996-05-13 DE DE69613694T patent/DE69613694T2/de not_active Expired - Fee Related
- 1996-05-13 JP JP53496596A patent/JP3641667B2/ja not_active Expired - Fee Related
- 1996-05-13 EP EP96915773A patent/EP0828522B1/en not_active Expired - Lifetime
- 1996-05-13 AU AU57459/96A patent/AU702481B2/en not_active Ceased
- 1996-05-13 WO PCT/US1996/006839 patent/WO1996036371A1/en active IP Right Grant
- 1996-05-13 CA CA002221132A patent/CA2221132C/en not_active Expired - Fee Related
-
1998
- 1998-01-27 US US09/013,725 patent/US5854303A/en not_active Expired - Lifetime
-
2003
- 2003-12-24 JP JP2003426591A patent/JP4091536B2/ja not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
JP4091536B2 (ja) | 2008-05-28 |
EP0828522A1 (en) | 1998-03-18 |
US5739178A (en) | 1998-04-14 |
EP0828522B1 (en) | 2001-07-04 |
JP2004189746A (ja) | 2004-07-08 |
DE69613694T2 (de) | 2002-05-16 |
AU5745996A (en) | 1996-11-29 |
JP3641667B2 (ja) | 2005-04-27 |
DE69613694D1 (de) | 2001-08-09 |
US5854303A (en) | 1998-12-29 |
CA2221132A1 (en) | 1996-11-21 |
WO1996036371A1 (en) | 1996-11-21 |
AU702481B2 (en) | 1999-02-25 |
CA2221132C (en) | 2004-08-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP3641667B2 (ja) | アイケア製品中の眼の病原体の増殖を防止するためのポリマー、物品および方法 | |
EP0663409B1 (en) | Antimicrobial polymer, contact lens, and contact lens care products | |
EP1545635B1 (en) | Compositions with enhanced antimicrobial efficacy against acanthamoebae | |
US5536861A (en) | Monomers for producing antimicrobial quaternary group-containing polyers | |
CN100363061C (zh) | 包含活性银的抗微生物隐形眼镜及其生产方法 | |
DK163265B (da) | Fremgangsmaade til at bibringe desinficerende og/eller praeserverende aktivitet til en oftalmisk kontaktlinseoploesning, isaer til bloede kontaktlinser, samt fremgangsmaade til desinficering af isaer bloede kontaktlinser | |
JP2002348338A (ja) | 新規の重合体抗菌剤類及び薬剤組成物へのそれらの使用 | |
WO1995010309A1 (en) | Method of inhibiting protozoan growth in eye care products using a polyvalent cation chelating agent | |
AU730031B2 (en) | Polymer, article and method for inhibiting the growth of ocular pathogens in eye care products | |
JP2019077661A (ja) | 眼科用剤 | |
EP0945141B1 (en) | Use of a liquid for disinfecting contact lenses | |
CN100337694C (zh) | 对棘阿米巴具有提高的抗菌功效的组合物 | |
JPH11147918A (ja) | 水可溶性抗菌ポリマーおよびそれからなるコンタクトレンズ用液剤 | |
JPH05161694A (ja) | コンタクトレンズの処理方法 | |
EP1852133A2 (en) | Compositions with enhanced antimicrobial efficacy against acanthamoebae | |
JP2007513383A (ja) | 自己保存性溶液用の穏和な保存剤組成物 | |
JP2007512906A (ja) | 穏和な強化保存剤系 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20031224 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20040323 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20040618 |
|
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20040831 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20041130 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20041207 |
|
R150 | Certificate of patent or registration of utility model |
Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
LAPS | Cancellation because of no payment of annual fees |